We will discuss the pathobiology of some factors involved in the local immune response in the cornea:
(1) the influence of neovascularisation and Langer hans cells in the cornea on graft survival and viral infections; (2) the presence of immunosuppressive factors in the anterior chamber; and (3) the production of immunosuppressive factors by the cornea. We will discuss some in vitro tests that demonstrate that even a human cornea suffering from bullous keratopathy is still able to induce an immunosuppressive effect. almost all grafts placed on a vascularised recipient cornea failed, while grafts placed on a non-vascu larised recipient bed usually survived. Williams and CosterlO set up a genetically well-defined system in the rat, and observed that following grafting into vascularised . recipient corneas, rejection not only occurred more often, but also at an earlier time point. Vessels can probably be regarded as 'highways' for the influx of immunologically active cells, although an additive role in sensitisation cannot be excluded. Vessels may also be an indicator for another essential factor, i.e. the presence of Langerhans cells (LCs). These antigen-presenting cells are absent from the centre of a normal, healthy cornea, but in diseases that are known to carry a poor graft prognosis the cornea contains large numbers of antigen-presenting cells prior to transplantation (see review I I ). Gillette et al.12 determined the number of LCs in various corneal diseases. Many LCs were seen in herpes simplex infection (300-5001 mm2) and keratitis (200-400/mm2), and low numbers were observed in Fuchs' endothelial decompensation (0-100/mm2) and keratoconus (0-25/mm2). The first two diseases carry a poor graft prognosis, the latter two a good prognosis. Corneas with secondary decompensation following cataract surgery carry intermediate numbers of LCS,1 3 and show intermedi ate graft survival.
NEOVASCULARISATION AND LANGERHANS CELLS IN THE CORNEA
LCs are antigen-presenting cells that are able to pick up foreign antigen and carry it to the lymphatic system. Although their exact route from the eye to the lymph node has yet to be elucidated, it is likely that immunisation against a graft occurs more frequently when the recipient cornea contains many LCs. The effect of the presence of LCs in the cornea has not only' been suggested on the basis of circumstantial evidence but has also been demonstrated experimen tally in an animal model.4.14 Injection of latex beads into the central cornea stimulated LC migration to the corneal centre and subsequent grafting into these corneas led to a rejection rate of 98% instead of the normal 55%. Depletion of LCs in the corneal bed prior to transplantation could possibly be a way of obtaining better graft survival in man. Following transplantation, this effect is already used by clin icians: application of corticosteroids leads to lower numbers of LCs in the cornea and a decrease in their antigen-presenting capacity.12,15 Good surgery with careful trephination and buried knots will probably contribute to the prevention of influx of LCs into the cornea as well. experimental model of herpes simplex infection in mice. Stromal keratitis in herpes simplex infection is probably mediated by a virus-specific T cell response.1 7 Since the presence of antigen-presenting cells is necessary for the development of a T cell mediated immune response, it was hypothesised that an abnormal presence of high numbers of LCs in the cornea would stimulate an increased local immune response. IS To test this hypothesis, cautery was applied to the centre of the cornea in BALB/c mice. This treatment induces migration of LCs to the centre of the cornea. 19 In normal eyes, snout infection with HSV-I led to zosteriform spread of virus, with a low incidence of stromal keratitis. After cautery, however, mice developed keratitis more frequently, with a much greater severity and with an increased involvement of the iris. The higher incidence and severity of herpetic keratitis in corneas containing LCs in their centre was asso ciated with an earlier onset of a T-ceIl-mediated response, which subsequently endangered the integ rity of the eye.IS The normal cornea is able to protect itself to some degree from the vision-decreasin § effect of an anti-viral local immune response.2 Specific immunosuppressive factors have recently been identified in the cornea (see below).
INFLUENCE OF THE CORNEA ON THE ANTERIOR CHAMBER
Many experimental studies have focused on the specific regulation of immune responses in the anterior chamber of the eye, where immunosuppres sive factors were identified some time ago. An antigen placed in the anterior chamber will be presented to the immune system through Schlemm's canal and the bloodstream, and not through the lymphatic system. This results in a specific type of immune response with suppression of a systemic delayed type hypersensitivity (DTH) response, the development of a humoral response without complement-fixing antibodies and normal cytotoxic T cell responses. However, since inflammation in the eye inhibits the development of ACAID, it was tested whether inflammation-related cytokines were able to inhibit the in vitro ACAID-promoting activity of TGF-f3.29 Both IL-1f3 and IFNy were able to antagonise the ACAID-inducing effect of TGF-f3. The aqueous humour does not only modulate antigen presentation, but in itself has an immunosup pressive effect. Aqueous humour can inhibit mitogen (LPS, PHA and Con AJ and allo-antigen driven T cell proliferation in vitro.3 ,31 In vitro cultures of murine iris and ciliary body cells (I-CB) were established32 and supernatants were harvested and assayed for their in vitro ability to inhibit T lymphocyte activation. Murine I-CB cell-derived supernatants were able to suppress allo-antigen driven T cell proliferation in a mixed leucocyte reaction (MLR) and inhibited IL-2 production by a T cell hybridoma. The inhibitory factor in this case has not been identified, but is neither TGF-f3 nor prostaglandin. Other factors may be identified as well. Knisely et al?3 reported that the aqueous humour contained biologically relevant concentrations of glucocorti coids and that cortisol-binding globulin is relatively absent so that glucocorticoids are largely unbound. Variations in the level of these molecules in different diseases need to be studied, since they may play a critical role in the immunological equilibrium.
EXPERIMENTAL WORK ON THE PRODUCTION OF SUPPRESSI VE FACTORS IN THE CORNEA

Introduction
In addition to the presence of LCs in the cornea, other factors may determine whether or not an immune response will take place in the cornea. Sano and Streilein34 noticed that not only murine I-CB cells but also a normal murine cornea that is kept in culture produced factors that suppressed a murine MLR. Sano and Streilein subsequently tested which treatment modalities that are known to change the corneal environment were able to influence the production of the MLR suppressive factor: both cauterisation and a corneal incision were able' to interfere with the production of immunosuppressive factors. We hypothesised that the pathological changes in the human cornea brought on by disease might interfere with the local production of such factors as well. We therefore obtained normal donor corneas and corneas from eyes undergoing corneal transplantation and tested whether the supernatant of such corneas was able to inhibit the murine MLR. We wondered whether there was any difference in the production of suppressive factors between the corneal centre and the periphery, which normally does contain Langerhans cells as APCs. While the central cornea induced immunosuppression, the peripheral cornea did not, and even stimulated the MLR slightly (see Table I ). We conclude that not only murine but also human corneal tissue produces immunosuppressive factors when cultured in vitro, and that with regard to the cornea there is a differential effect between the centre and the periphery. Further studies showed that the factor involved is neither prostaglandin nor TGF-f3. 35 Immunosuppression by Diseased Corneal Tissue. Tissue obtained from the central cornea produced (an) immunosuppressive factor(s), while tissue from the peripheral cornea did not. We therefore hypothesised that inflamed or vascularised corneas containing APCS12, 36 , 37 or vessels would not produce any immunosuppressive factors, and would resemble peripheral corneal tissue. We were able to obtain corneal tissue from 18 eyes with bullous keratopathy and one with keratoconus, with different amounts of ves ' sel ingrowth. The level of inhibition of the MLR varied from 29% to 83%, with a mean of 65%. This was not significantly different from the amount of immunosuppression induced with the supernatant from normal corneas (n =: 6, average MLR inhibition 60%). There was no significant correlation between the extent of immunosuppression induced by pathological corneas and the amount of corneal vessel ingrowth prior to transplantation (p =: 0.2).
Materials and Methods
IMMUNOSUPPRESSIVE FACTORS PRODUCED BY DIFFERENT LAYERS OF THE CORNEA: LITERATURE
Little is known about the nature of corneal immunosuppressive factors, but others have shown that several different layers of the cornea are able to make immunosuppressive factors. Although the iris is supposed to be the main source of TGF-I3. some TGF-13 is produced by the cornea?8 However. often the nature of the factor is not known. and is not TGF-(3 or prostaglandin.
Originally, experiments were set up to test whether corneal cells obtained from the stroma were able to function as allo-antigen presenting cells and could stimulate proliferation of allogeneic lymphocytes. It was noticed that even after pre-treatment with interferon-)" human corneal fibroblasts induced only minimal lymphocyte proliferation. The effect was really the opposite of what had been expected. In addition, co-cultivation of human corneal fibro blasts with peripheral blood leucocytes (PBLs) in the presence of Con A or PHA inhibited mitogen induced lymphocyte proliferation by 40-90%?9 The inhibition could be partly reversed by addition of indomethacin. Young and Stark4 0 had performed a similar study and compared the inhibitory effect of HLA-DR-positive and -negative human corneal fibroblasts. Although DR-positive cells were expected to stimulate an immune response, this was not the case: both DR-positive and DR-negative fibroblasts inhibited T cell proliferation in a third party mixed leucocyte response.
Recently. several articles describing this phenom enon and the elusive factor have been published. According to Donnelly et al. 41 the immunosuppres sive effect of human corneal fibroblasts on the MLR of two unrelated third party cells depended on the continuous presence of the cells and their continuous production of a soluble inhibitory factor. Addition of interferon-), increased the inhibitory effect. while indomethacin had no effect. indicating that prosta glandins are not involved in this model.
Shams et al. 4 2 working with another corneal layer, i.e. epithelium obtained from human corn eo-scleral conjunctival rims. observed that the immunosuppres sive factor worked across species barriers. A differential effect was observed between paraformal dehyde-fixed and unfixed cells: while fixed cells could still inhibit T cells by direct cell-cell contact. their supernatant no longer had an immunosuppressive effect. Only unfixed cells produced the suppressive soluble factor. which could be inhibited by addition of indomethacin.
The third corneal layer. the endothelium, was studied extensively by Gregerson and coworkers. They have reported that monolayers of LEW rat corneal endothelial (CE) cells inhibit in vitro T lymphocyte proliferation and IL-2 production in response to antigen or the mitogen Con A. 43-4 7 This phenomenon was observed using several rat and murine CD4 T cell lines. several T cell hybridomas and fresh rat lymphocytes. Initial studies showed that the inhibition of T cell proliferation by CE cells is neither MHC-restricted nor species-specific, since LEW rat CE cells inhibited both rat and murine T cells. Furthermore. rabbit. cat and human CE cells also inhibited both rat and murine T cells:BA4 Induction of MHC class II expression on the CE cells by IFN-)' did not affect their inhibitory activity. nor did it allow them to stimulate antigen-specific IL-2 production by several T cell hybridomas. 43.46 Although the activity has not yet been identified. the inhibition was not suppressed by indomethacin. suggesting that it is not prostaglandin E. The inability of neutralising anti bodies to TGF-(31 and TGF-132 to reverse the inhibition suggests that the activity is not TGF- (3.45 That the inhibitory effect of the CE cells is not due production and growth inhibition/IL-2Ra expres sion. Once activated, the lymphocytes are no longer susceptible to the inhibitory activity.
The nature of the inhibitory activity is currently unclear. Cell-free CE cell conditioned medium has some ability to inhibit lympho-proliferation assays, but it is much less potent than direct contact with the 
